1-(4-nitrophenyl)sulfonyl-1,2,4-triazole | CAS:57777-84-1

We serve 1-(4-nitrophenyl)sulfonyl-1,2,4-triazole CAS:57777-84-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-(4-nitrophenyl)sulfonyl-1,2,4-triazole

Chemical Name:1-(4-nitrophenyl)sulfonyl-1,2,4-triazole
CAS.NO:57777-84-1
Synonyms:1-(p-nitrobenzenesulfonyl)-1H-1,2,4-triazole;1-(4-nitro-benzenesulfonyl)-1H-[1,2,4]triazole;p-NBST
Molecular Formula:C8H6N4O4S
Molecular Weight:254.22300
 
Physical and Chemical Properties:
Density:1.49;
Melting point:140-142oC;
Boiling point:506.4oC;
Flash point:260oC;
Index of Refraction:1.726;
 
Specification:
Appearance:White to light yellow crystalline powder
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent



Contact us for information like 1-(4-nitrophenyl)sulfonyl-1,2,4-triazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-NBST physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(4-nitrophenyl)sulfonyl-1,2,4-triazole Use and application,1-(p-nitrobenzenesulfonyl)-1H-1,2,4-triazole technical grade,usp/ep/jp grade.


Related News: The videos have gone viral on Chinese social media and have been praised as a novel way to raise awareness of the disease.7,8-dimethoxy-1,2,3,5-tetrahydro-3-benzazepin-4-one manufacturer Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.Pyrrolo[2,3-d]pyrimidin-4-ol supplier Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.5-Methyl-2-pyrazinecarboxylic acid vendor With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.